CAPLIPOINT — Caplin Point Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹174.93bn
- IN₹164.61bn
- IN₹21.87bn
India's Caplin Point at near 6-month high on Q4 profit growth
India's Caplin Point Lab near 3-month high on FDA nod to new drug
Brief: Caplin Point Laboratories Says Caplin Steriles Gets USFDA Approval For Ketorolac Tromethamine Injection
India's Caplin Point Laboratories hits near 2-year low
Brief: Caplin Point Laboratories Unit Gets USFDA Approval For Thiamine Hydrochloride Injection
Brief: Caplin Point Laboratories Says Unit Gets USFDA Approval For Rocuronium Bromide Injection
India's Caplin Point rises on US FDA nod to unit for muscle relaxation drug
Brief: Caplin Point Laboratories Says Unit Gets USFDA Approval For Rocuronium Bromide Injection
Brief: India's Caplin Point Laboratories June-Quarter Profit Rises
Brief: India's Caplin Point Laboratories Dec-Qtr Consol Net Profit Rises
Brief: India's Caplin Point Laboratories Sept-Quarter Consol Net Profit Rises
Cro Amaris Clinical Completes USFDA Audit With Nil Observations
Brief: India's Caplin Point Laboratories June-Qtr Consol Net Profit Rises
Brief: Caplin Steriles Gets U.S. FDA Approval For Sumatriptan Injection
Brief: India's Caplin Point Laboratories March-Qtr Consol Net Profit Rises
Brief: Caplin Point Labs Gets USFDA Approval For Argatroban Injection
Brief: Caplin Point Says Caplin Steriles Enters Strategic Partnership With Jamp Pharma For Canada
Brief: Caplin Point Laboratories Gets U.S. FDA Approval For Etomidate Injection USP
Brief: Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals